← All trials
NCT05453552
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2022
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2024
- First posted
- Jul 12, 2022
- Last posted
- Jul 12, 2022
- Enrollment
- 242
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Southern Medical UniversityLead sponsor
- Guangzhou Medical UniversityCollaborator
- Peking UniversityCollaborator
- First People's Hospital of ChenzhouCollaborator
- Southern Medical UniversityOverall official - principal investigator
- Southern Medical UniversityReponsible party - principal investigator
- Sun Yat-Sen UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Chinese Academy of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.